Autonomix Medical, Inc.
AMIX· Nasdaq
Released Nov 8, 2024, after the close
10-Q filed Nov 8, 2024, 39 days after period end · 0001437749-24-034230
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | — |
| Net Income | -$2.81M | -$6.04M | -$448.00K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Autonomix Medical, Inc. · CIK 1617867 · Engraved from SEC EDGAR
ended Sep 30, 2024 · filed Nov 8, 2024 · 39 d after period end
2.8% from the close of Nov 8, 2024 to the close of Nov 11, 2024, the first after the release.